EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid

Andrew Harper, Maike Chapel, Grace Hodgson, Krzysztof Malinowski, Imogen Yates, Michael Garle, Vera Ralevic

Vascular Pharmacology · 2023

DOI: 10.1016/j.vph.2023.107199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Pharmacology, 2023. Verfasst von Andrew Harper und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Coronary Vessels, Hydrogen Sulfide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Myeloperoxidase (MPO) and its principal reaction product hypochlorous acid (HOCl) are part of the innate immune response but are also associated with endothelial dysfunction, thought to involve a reduction in nitric oxide (NO) bioavailability. We aimed to investigate the effect of MPO and HOCl on vasorelaxation of coronary arteries and to assess directly the involvement of NO. In addition, we hypothesised that the slow release hydrogen sulfide (H2S) donor GYY4137 would salvage coronary artery endothelial function in the presence of MPO and HOCl. METHODS AND RESULTS: Contractility of porcine coronary artery segments was measured using isometric tension recording. Incubation with MPO (50 ng/ml) plus hydrogen peroxide (H2O2) (30 μM; substrate for MPO) impaired endothelium-dependent vasorelaxation to bradykinin in coronary arteries. HOCl (10-500 μM) also impaired endothelium-dependent relaxations. There was no effect of MPO plus H2O2, or HOCl, on endothelium-independent relaxations to 5'-N-ethylcarboxamidoadenosine and sodium nitroprusside. L-NAME (300 μM), a NO synthase inhibitor, attenuated bradykinin relaxations, leaving L-NAME-resistant relaxations to bradykinin mediated by endothelium-dependent hyperpolarization. In the presence of L-NAME, MPO plus H2O2 largely failed to impair endothelium-dependent relaxations to bradykinin. Similarly, HOCl failed to inhibit endothelium-dependent relaxations to bradykinin in the presence of L-NAME. GYY4137 (1-100 μM) protected endothelium-dependent relaxations to bradykinin from dysfunction caused by MPO plus H2O2, and HOCl, with no effect alone on bradykinin relaxation responses. The specific MPO inhibitor aminobenzoic acid hydrazide (ABAH) (1 and 10 μM) also protected against MPO plus H2O2-induced endothelial dysfunction (at 10 μM ABAH), but was less potent than GYY4137. CONCLUSIONS: MPO plus H2O2, and HOCl, impair coronary artery endothelium-dependent vasorelaxation via inhibition of NO. GYY4137 protects against endothelial dysfunction in arteries exposed to MPO plus H2O2, and HOCl. H2S donors such as GYY4137 are possible therapeutic options to control excessive MPO activity in cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary VesselsHydrogen SulfideAnimalsSwineHypochlorous AcidNG-Nitroarginine Methyl EsterBradykininPeroxidaseHydrogen PeroxideNitric OxideEndothelium, VascularMorpholinesOrganothiophosphorus Compounds

Stichwörter der Autor:innen

Coronary arteryEndotheliumHydrogen sulfideHypochlorous acidMyeloperoxidase

Substanzen

Hypochlorous AcidHydrogen SulfideNG-Nitroarginine Methyl EsterBradykininPeroxidaseHydrogen PeroxideNitric OxideGYY 4137MorpholinesOrganothiophosphorus Compounds

Autor:innen und Institutionen

  • School of Life Sciences, University of Nottingham, Nottingham, UK.
  • School of Life Sciences, University of Nottingham, Nottingham, UK. Electronic address: vera.ralevic@nottingham.ac.uk.

Zitieren

APA

Harper, A., Chapel, M., Hodgson, G., Malinowski, K., Yates, I., Garle, M., & Ralevic, V. (2023). GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2023.107199

Vancouver

Harper A, Chapel M, Hodgson G, Malinowski K, Yates I, Garle M, et al. GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid. Vascular Pharmacology. 2023. doi:10.1016/j.vph.2023.107199

BibTeX
@article{Harper2023,
  author = {Harper, Andrew and Chapel, Maike and Hodgson, Grace and Malinowski, Krzysztof and Yates, Imogen and Garle, Michael and Ralevic, Vera},
  title = {GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid},
  journal = {Vascular Pharmacology},
  year = {2023},
  doi = {10.1016/j.vph.2023.107199}
}
Kostenlos starten →